NewSquare Capital LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
NewSquare Capital LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,730
-9.5%
5950.0%0.00%0.0%
Q2 2023$6,331
+1.2%
5950.0%0.00%0.0%
Q1 2023$6,259
-15.1%
5950.0%0.00%0.0%
Q4 2022$7,372
+22.9%
5950.0%0.00%0.0%
Q3 2022$6,000
-14.3%
5950.0%0.00%0.0%
Q2 2022$7,0000.0%5950.0%0.00%0.0%
Q1 2022$7,0000.0%5950.0%0.00%0.0%
Q4 2021$7,000
-12.5%
5950.0%0.00%0.0%
Q3 2021$8,0000.0%5950.0%0.00%0.0%
Q2 2021$8,0005950.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$188,977,00019.02%
13D Management LLC 600,431$6,923,0003.06%
BRIDGER MANAGEMENT, LLC 956,014$11,023,0002.48%
Brown Capital Management 11,641,935$134,232,0001.80%
Price Jennifer C. 520,000$5,996,0001.02%
Monarch Partners Asset Management LLC 272,425$3,141,0000.88%
ALPHASIMPLEX GROUP, LLC 10,510$121,0000.86%
Intrinsic Value Partners, LLC 54,105$624,0000.80%
CLARK ESTATES INC/NY 355,000$4,093,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 692$60,000,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders